WIPO
open access
The impact of the pharmaceutical industry on the innovation performance of European countries
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Is Europe a Laggard in Pharmaceuticals? R&D Joint Ventures, Patent Quality and R&D Productivity#1026057
- Pharmaceutical Public-Private Partnerships in the United States and Europe: Moving from the Bench to the Bedside#271038
- In Pursuit of Profitability and Effectiveness in the Global Pharmaceutical Industry: Comments on Professor Walker's Four Challenges#493931
- Impact of China's national drug price negotiation on pharmaceutical firms' innovation activities.#228032
- FEATURES OF ENTERING ENTREPRENEURIAL ACTIVITY IN THE PHARMACEUTICAL SECTOR#208030
Record · ID 271035
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive